On estimating the polyclonal fraction in lineage-marker studies of tumor origin

Author： Newton Michael A.  

Publisher： Oxford University Press

ISSN： 1465-4644

Source： Biostatistics, Vol.7, Iss.4, 2006-10, pp. : 503-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estimating the diagnostic likelihood ratio of a continuous marker

By Gu Wen   Pepe Margaret Sullivan  

Biostatistics, Vol. 12, Iss. 1, 2011-01 ,pp. : 87-101

Oxford University Press

Access to resources Recommend Favorite

Estimating the capacity for improvement in risk prediction with a marker

By Gu Wen   Pepe Margaret Sullivan  

Biostatistics, Vol. 10, Iss. 1, 2009-01 ,pp. : 172-186

Oxford University Press

Access to resources Recommend Favorite

Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

By  

Cardiology, Vol. 134, Iss. 3, 2016-03 ,pp. : 311-319

Karger

Access to resources Recommend Favorite

Estimating and modeling the cure fraction in population-based cancer survival analysis

By Lambert Paul C.   Thompson John R.   Weston Claire L.   Dickman Paul W.  

Biostatistics, Vol. 8, Iss. 3, 2007-07 ,pp. : 576-594

Oxford University Press

Access to resources Recommend Favorite

Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1163-1177

John Wiley & Sons Inc

Access to resources Recommend Favorite